Literature DB >> 25004344

Birth weight percentile and the risk of term perinatal death.

Alexandros A Moraitis1, Angela M Wood, Michael Fleming, Gordon C S Smith.   

Abstract

OBJECTIVE: To estimate the association between birth weight percentile and the risk of perinatal death at term in relation to the cause of death.
METHODS: We performed a retrospective cohort study of all term singleton births in delivery units in Scotland between 1992 and 2008 (n=784,576), excluding perinatal deaths ascribed to congenital anomaly.
RESULTS: There were 1,700 perinatal deaths in the cohort, which were not the result of congenital anomaly (21.7/10,000 women at term). We observed a reversed J-shaped association between birth weight percentile and the risk of antepartum stillbirth in all women, but the associations significantly differed (P<.001) according to smoking status. The highest risk (adjusted odds ratio referent to 21st-80th percentile, 95% confidence interval) among nonsmokers was for birth weight third or less percentile (10.5, 8.2-13.3), but there were also positive associations for birth weight percentiles 4th-10th (3.8, 3.0-4.8), 11th-20th (1.9, 1.5-2.4), and 98th-100th (1.8, 1.3-2.4). Among smokers, the associations with being small were weaker and the associations with being large were stronger. We also observed a reversed J-shaped association between birth weight percentile and the risk of delivery-related perinatal death (ie, intrapartum stillbirth or neonatal death), but there was no interaction with smoking. The highest risk was for birth weight greater than the 97th percentile (2.3, 1.6-3.3), but there were also associations with third or less percentile (2.1, 1.4-3.1), 4th-10th (1.8, 1.4-2.4), and 11th-20th (1.5, 1.2-2.0). Analysis of the attributable fraction indicated that approximately one in three antepartum stillbirths and one in six delivery-related deaths at term could be related to birth weight percentile outside the range 21st-97th percentile.
CONCLUSION: Effective detection of variation in fetal size at term has potential as a screening test for the risk of perinatal death. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2014        PMID: 25004344     DOI: 10.1097/AOG.0000000000000388

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  20 in total

1.  Universal late pregnancy ultrasound screening to predict adverse outcomes in nulliparous women: a systematic review and cost-effectiveness analysis.

Authors:  Gordon Cs Smith; Alexandros A Moraitis; David Wastlund; Jim G Thornton; Aris Papageorghiou; Julia Sanders; Alexander Ep Heazell; Stephen C Robson; Ulla Sovio; Peter Brocklehurst; Edward Cf Wilson
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

2.  Fetus-derived DLK1 is required for maternal metabolic adaptations to pregnancy and is associated with fetal growth restriction.

Authors:  Mary A M Cleaton; Claire L Dent; Mark Howard; Jennifer A Corish; Isabelle Gutteridge; Ulla Sovio; Francesca Gaccioli; Nozomi Takahashi; Steven R Bauer; D Steven Charnock-Jones; Theresa L Powell; Gordon C S Smith; Anne C Ferguson-Smith; Marika Charalambous
Journal:  Nat Genet       Date:  2016-10-24       Impact factor: 38.330

3.  Fetal weight estimation by automated three-dimensional limb volume model in late third trimester compared to two-dimensional model: a cross-sectional prospective observational study.

Authors:  Hua Meng; Yunshu Ouyang; Xining Wu; Zihan Niu; Zhonghui Xu; Yuxin Jiang; Yixiu Zhang
Journal:  BMC Pregnancy Childbirth       Date:  2021-05-08       Impact factor: 3.007

4.  Correlates of poor perinatal outcomes in non-hospital births in the context of weak health system: the Nigerian experience.

Authors:  Peter Onubiwe Nkwo; Lucky Osaheni Lawani; Euzebus Chinonye Ezugwu; Chukwuemeka Anthony Iyoke; Agozie C Ubesie; Robinson Chukwudi Onoh
Journal:  BMC Pregnancy Childbirth       Date:  2014-09-30       Impact factor: 3.007

5.  Diagnostic accuracy of placental growth factor and ultrasound parameters to predict the small-for-gestational-age infant in women presenting with reduced symphysis-fundus height.

Authors:  M Griffin; P T Seed; L Webster; J Myers; L MacKillop; N Simpson; D Anumba; A Khalil; M Denbow; A Sau; K Hinshaw; P von Dadelszen; S Benton; J Girling; C W G Redman; L C Chappell; A H Shennan
Journal:  Ultrasound Obstet Gynecol       Date:  2015-07-03       Impact factor: 7.299

6.  Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia.

Authors:  M Griffin; P T Seed; S Duckworth; R North; J Myers; L Mackillop; N Simpson; J Waugh; D Anumba; L C Kenny; C W G Redman; A H Shennan; L C Chappell
Journal:  Ultrasound Obstet Gynecol       Date:  2018-02-07       Impact factor: 7.299

7.  Fractional fetal thigh volume in the prediction of normal and abnormal fetal growth during the third trimester of pregnancy.

Authors:  Louise E Simcox; Jenny E Myers; Tim J Cole; Edward D Johnstone
Journal:  Am J Obstet Gynecol       Date:  2017-06-23       Impact factor: 8.661

8.  Influence of Birthweight on the Prospective Stillbirth Risk in the Third Trimester: A Cross-Sectional Cohort Study.

Authors:  Stephen Contag; Clayton Brown; Sarah Crimmins; Katherine Goetzinger
Journal:  AJP Rep       Date:  2016-07

9.  Screening for fetal growth restriction with universal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study.

Authors:  Ulla Sovio; Ian R White; Alison Dacey; Dharmintra Pasupathy; Gordon C S Smith
Journal:  Lancet       Date:  2015-09-07       Impact factor: 79.321

10.  Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restriction.

Authors:  Jezid Miranda; Rui V Simões; Cristina Paules; Daniel Cañueto; Miguel A Pardo-Cea; María L García-Martín; Francesca Crovetto; Rocio Fuertes-Martin; Monica Domenech; María D Gómez-Roig; Elisenda Eixarch; Ramon Estruch; Stefan R Hansson; Nuria Amigó; Nicolau Cañellas; Fatima Crispi; Eduard Gratacós
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.